Biography

Guido Kroemer is currently (since 2010) Professor at the Faculty of Medicine of the University of Paris Cité, Director of the research team "Metabolism, Cancer and Immunity" of the French Medical Research Council (INSERM), Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Comprehensive Cancer Center, and Hospital Practitioner at the Hôpital Européen George Pompidou, Paris, France. Kroemer is the director of the LabEx Immuno-Oncology, director of the Equipex Onco-Pheno-Screen, president of the European Academy of Tumor Immunology (EATI), and president-elect of the, European Network for Cancer Immunotherapy (ENCI).

Prior to joining the French Medical Research Council (INSERM, 1994-2010), Kroemer was Senior Scientist of the European Community at the Spanish National Research Council (CSIC), at the National Center of Molecular Biology (1990-1992) and at the National Center of Biotechnology (1993). Dr. Kroemer did his post-doctoral training at the Collège de France, Nogent-sur-Marne (1988-1989), and at the University of Innsbruck, Austria, after receiving his PhD/MD degree at the same University in 1985. He also holds a PhD degree in Molecular Biology (Autonomous University of Madrid, 1992). He was the Director of the Paris Alliance of Cancer Research Institutes (PACRI) from 2013 to 2017. He was Foreign Adjunct Professor at the Karolinska Institute, Stockholm, Sweden (2016-2021), Honorary Professor at the Suzhou Center of Systems Medicine, Chinese Academy of Medical Sciences (2016-2019), and held the Oon Chiew Seng Distinguished Professorship of the National University of Singapore (2019).

Kroemer discovered that the permeabilization of mitochondrial membranes constitutes a decisive step in programmed cell death, as well as the detailed mechanisms that make cancer cell death immunogenic in the context of successful antineoplastic treatments. In recent years, he has worked on the link between cellular stress and autophagy, as well as the stimulation of autophagy for improving health span and lifespan in model organisms. His more than 1500 publications have been cited >335,000 times (h-index=271) according to Google Scholar and >241,000 times according to the Web of Science (Thomson Reuters) (h-index=230).

Kroemer is the founding Editor-in-Chief of six journals: Cell Death & Disease (Nature Publishing Group, Springer), Cell Stress (Shared Science), OncoImmunology (Taylor & Francis), Microbial Cell (Shared Science), MedComm Cancer (Wiley and SCIMEA), Molecular & Cellular Oncology (Taylor & Francis). He is also the Editor-in-Chief of Seminars in Immunology (Elsevier).

Kroemer is an elected member of Academia Europaea, Academy for Health and Lifespan Research, Austrian Academy of Sciences, Chinese Academy of Engineering (CAE), European Academy of Sciences (EAS), European Academy of Tumor Immunology (EATI), European Academy of Sciences and Arts (EASA), European Academy of Cancer Sciences (EACS), European Molecular Biology Organization (EMBO), German Academy of Sciences (Leopoldina), and Institut Universitaire de France (IUF).

Kroemer’s contributions have been recognized by the Monika Kutzner Prize of the Berlin-Brandenburg Academy of Sciences (1998), the Gallet & Breton Prize of the French Academy of Medicine (1999), the Descartes Prize of the European Union (2006), the Carus Medal of the German Academy of Sciences (2007), the Grand Prix Mergier-Bourdeix of the French Academy of Sciences (2007), the Lucien Dautrebande Prize of the Belgian Royal Academy of Medicine (2009), the Duquesne Prize of the French National League against Cancer (2010), the ‘Coup d'Elan’ Prize of the Bettencourt-Schueller Foundation (2011), the Léopold Griffuel Prize of the French Association for Cancer Research (2012), a European Research Council (ERC) Advanced Investigator Award (2013), the Mitjavile Prize of the French Academy of Medicine (2014), the Galien Prize for Pharmacological Research (2015), the Grand Prix Claude Bernard of the City of Paris (2016), the Brupbacher Prize for Cancer Research (2017), the ADPS Prize for Longevity Research (2017), the Baillet-Latour Health Prize (2018), the Albert Struyvenberg Medal of the European Society for Clinical Investigation (2019), the Grand Prix “Pink Rubbon” of the Estée Lauder Companies (2019), the International Prize “Lombardy & Research” (2019), a Cancer Research ASPIRE Award of the Mark Foundation (2021), as well as European Research Council (ERC) Advanced Investigator Award (2023). Kroemer holds honorary doctoral degrees from the University of Buenos Aires (2011) and the University of Rome Tor Vergata (2019).